Patents Represented by Attorney Susan K. Lehnhardt
  • Patent number: 5958455
    Abstract: Methods of making tablets of a variety of physical forms are described. The tablets can be made into a wide variety of formulations. The invention further provides methods of making crystalline and amorphous anhydrous trehalose for use in formulating tablets suitable for use in dispensing pharmaceutical agents.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: September 28, 1999
    Assignee: Quadrant Holdings Cambridge Ltd
    Inventors: Bruce J. Roser, Julian Blair, Camilo Colaco, Ross Henry Morris Hatley
  • Patent number: 5859208
    Abstract: A human basic fibroblast growth factor (FGF) protein analog wherein the cysteine at positions 78 and 96 is replaced by serine, and said analog exhibits the biological activity of native, human basic FGF.The DNA sequences encoding analogs of human acidic and basic fibroblast growth factors (FGF) can be recombinantly expressed to obtain practical amounts of proteins useful in effecting both pathologies related to persistent angiogenesis and wound healing and related tissue repair.
    Type: Grant
    Filed: February 12, 1990
    Date of Patent: January 12, 1999
    Inventors: John C. Fiddes, Judith A. Abraham, Andrew A. Protter
  • Patent number: 5811537
    Abstract: The present invention is directed to oligonucleotides comprising nucleotide sequences sufficiently complementary to conserved regions of human immunodeficiency virus genetic material such that when bound to said region, the oligonucleotides effectively prevent expression of the genetic material.
    Type: Grant
    Filed: January 14, 1997
    Date of Patent: September 22, 1998
    Assignee: Novopharm Biotech Inc.
    Inventor: Albert D. Friesen
  • Patent number: 5762961
    Abstract: The invention provides methods of making rapidly soluble tablets of decreased weight compared to similar solid tablets. The invention further provides novel, rapidly soluble tablets of decreased weight compared to similar solid tablets. The tablets offer increased rates of dissolution and disintegration.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: June 9, 1998
    Assignee: Quadrant Holdings Cambridge Ltd.
    Inventors: Bruce J. Roser, Julian Blair
  • Patent number: D319108
    Type: Grant
    Filed: January 5, 1989
    Date of Patent: August 13, 1991
    Inventors: Jan van Weerden, Johannes Valkenburg, Ferdinand P. van der Spek
  • Patent number: D319316
    Type: Grant
    Filed: January 5, 1989
    Date of Patent: August 20, 1991
    Inventors: Jan van Weerden, Johannes Valkenburg, Ferdinand P. van der Spek